Capricor Therapeutics CAPR Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$114.59M-108% | -$105.04M-160% | -$81.99M-140% | -$69.98M-150% | -$55.06M-126% | ||
| $2.02M+34.6% | $1.89M+32.5% | $1.76M+29.8% | $1.63M+28.0% | $1.5M+28.1% | ||
| $17.4M+45.3% | $16.97M+73.8% | $15.42M+65.3% | $13.48M+49.8% | $11.98M+41.6% | ||
| -$92.63M-105% | -$69.81M-74.5% | -$61.04M-65.9% | -$52.99M-56.1% | -$45.16M-45.3% | ||
| $7.13M+390% | $2.9M+149% | $1.73M+39.8% | $1.68M+12.3% | $1.45M-7.5% | ||
| -$81.05M+2.1% | $97.48M+184% | -$68.99M— | -$82.94M— | -$82.79M— | ||
| $250.31M+66.3% | $248.89M+62.9% | $81.16M-14.4% | $148.48M+435% | $150.53M+440% | ||
| —— | —— | —— | —— | —— | ||
| -$99.76M-114% | -$72.72M-76.7% | -$62.77M-65.1% | -$54.68M-54.3% | -$46.62M-42.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Capricor Therapeutics's cash flow data come from?
- Every line is extracted from Capricor Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.